ReviewJournal of mammary gland biology and neoplasia2001
Myc and mammary cancer: Myc is a downstream effector of the ErbB2 receptor tyrosine kinase.
N E Hynes et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papercites it